Cervical Cancer - GEN - Genetic Engineering and Biotechnology News

Cervical Cancer

Viral-Bacterial Coinfection Can Reprogram Cells, Cause Cancer

The microbiome is the collection of microorganisms

Cervical Cancer

Microbiome May Identify Female Precancer Risk from HPV

Illustration of ovaries and womb

Cervical Cancer

Cervical Microbiome May Promote Cancer

Cervical Cancer

After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination

An FDA-approved test for the human papilloma virus (HPV) can detect the genotypes likely to cause cervical cancer in women. This test

Cervical Cancer

FDA Approves Cervical-Cancer-Related HPV Test

Cervical Cancer

BMS, Advaxis, Array Ink Independent Deals to Evaluate Combo Cancer Therapies

Cervical Cancer

Genticel to Shrink Workforce 30%

Cervical Cancer

New Biomarker Is Predictor of Metastatic Cancer

Cervical Cancer

FDA Places Advaxis Cancer Immunotherapy on Clinical Hold

Cervical Cancer

MedImmune Licenses Inovio Cancer Vaccine for Up-to $727.5M

Cervical Cancer

Kite Pharma, bluebird bio Partner on Cancer Immunotherapies

Cervical Cancer

Selecta Receives $3.2M from Skolkovo Foundation for Immuno-oncology Program

Cervical Cancer

Avastin Wins FDA Nod for Advanced Forms of Cervical Cancer

Cervical Cancer

Biocon, Advaxis Ink Deal for HPV-Associated Cervical Cancer Compound

Cervical Cancer

Advaxis, Global BioPharma Ink Licensing Agreement for HPV Candidate

12 3...5 Page 1 of 5